<DOC>
	<DOCNO>NCT01050725</DOCNO>
	<brief_summary>The purpose study determine whether specific assay DNA damage repair protein use patient undergoing radiation therapy . The ultimate goal research develop clinically useful biomarkers blood sample could use customize radiation treatment individual , lead reduced side effect improve outcome .</brief_summary>
	<brief_title>Pilot Study Biomarkers Radiation Therapy</brief_title>
	<detailed_description />
	<criteria>patient &gt; 18 year age primary lung , esophageal rectal cancer receive neoadjuvant chemoradiotherapy plan resection patient clinically localized prostate cancer receive definitive radiation therapy external beam treatment . brachytherapy boost and/or hormonal therapy allow . patient head neck , lung , esophageal cervical cancer receive definitive radiotherapy prior history chemotherapy give within 6 month enrollment . prior radiotherapy radionuclide treatment and/or brachytherapy within 6 month prior enrollment . unwillingness comply test , protocol , informed consent . concurrent enrollment protocol would require noncompliance treatment procedure . chemotherapy require within 2 hour follow first dose XRT . PET scan do within 48 hour first blood draw . nuclear medicine exposure within 4 day prior first draw .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>proteome</keyword>
	<keyword>biomarkers</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>cancer</keyword>
</DOC>